Headquarters: Lure, France
CEO: Mr. Matthieu Frechin
EUR as of July 1, 2023
|Company||Market Cap (USD)|
|Zoetis Inc.||$78.54 B|
|MERCK Kommanditgesellschaft auf Aktien||$70.69 B|
|Takeda Pharmaceutical Company Limited||$46.59 B|
|Haleon plc||$37.99 B|
|Eisai Co. Ltd||$17.26 B|
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of pain management, anti-infective, cardiology-nephrology, care and hygiene, antiparasiticides, behavior, internal medicine, and reproduction for cats, dogs, cattle, and pigs. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
Unlock the Power of Financial AI:
Try Disfold AI Free for 7 Days!